PROGNOSTIC VALUE OF NT-PROBNP IN ASSESSING THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH PREDIABETES AT THE OUTPATIENT STAGE: TWO-YEAR PROSPECTIVE FOLLOW-UP Prognostic value of NT-proBNP in assessing the risk of cardiovascular events in patients with prediabetes at the outpatient stage: two-year prospective follow-up

Published in Medical Bulletin of the Ministry of Internal Affairs · Issue 5, 2026 · Pages 55–59 · Rubric: Interrnal diseases
DOI: https://doi.org/10.52341/20738080_2026_144_5_55
Received: 07.10.2026 Accepted: 23.10.2026 Published: 23.10.2026 Language of publication: RUS
The role of natriuretic peptides and gender features of the factors of cardiometabolic risk in individuals with prediabetes remain insufficiently studied, which is reflected in the presented study.
prediabetes, diabetes mellitus, ntprobnp, cardiovascular risk, outpatient stage, gender differences, cardiovascular diseases
Text References
Text (PDF)
Read Download

1. McDonagh T.A. et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure // European Heart Journal. – 2021; 42(36): 3599–3726. https://doi.org/10.1093/eurheartj/ehab368

2. American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes – 2024 // Diabetes Care. – 2024; 47(Suppl 1): S20–S42. https://doi.org/10.2337/dc24-S002

3. Genitsaridi I., Salpea P., Salim A. et al. 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050 // The Lancet Diabetes & Endocrinology. – 2025; 14,149–156. https://doi.org/10.1016/S2213-8587(25)00299-2

4. Pieske B. et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithmic function // European Heart Journal. – 2019; 40(40):3297–3317. Doi:https://doi.org/10.1093/eurheartj/ehz641

5. Seferović P.M. et al. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology // European Journal of Heart Failure. – 2018; 20(5):853–872. Doi:https://doi.org/10.1002/ejhf.1170

6. Kim H.N., Januzzi J.L. Jr. Natriuretic peptide testing in heart failure // Circulation. – 2011; 123(18):2015–2019. Doi:https://doi.org/10.1161/CIRCULATIONAHA.110.979500

7. Liu H.H., Cao Y.X., Jin J.L., Guo Y.L., Zhu C.G., Wu N.Q., Gao Y., Zhang Y., Xu R.X., Dong Q., Li J.J. Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study // Cardiovasc Diabetol. – 2021; 20(1):84. Doi:https://doi.org/10.1186/s12933-021-01271-0

8. Brannick B., Dagogo-Jack S. Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction // Endocrinol Metab Clin North Am. – 2018; 47(1):33–50. Doi:https://doi.org/10.1016/j.ecl.2017.10.001

9. Marco Witkowski, Yuping Wu W.H, Wilson Tang. NT-proBNP and cardiovascular event risk in individuals with prediabetes undergoing cardiovascular evaluation // Diabetes Res Clin Pract. – 2023:205:110923. Doi:https://doi.org/10.1016/j.diabres.2023.110923